Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AIDS and transfer factor: myths, certainties and realities

D Viza1

  • 1Laboratoire d'Immunobiologie, URA 1294 CNRS, Faculté de Médecine des Saints-Pères, Paris, France.

Biotherapy (Dordrecht, Netherlands)
|January 1, 1996
PubMed
Summary

Transfer factor, a concept in immunology, faces skepticism despite its potential for treating viral infections. Overcoming scientific dogma may allow its acceptance for conditions like AIDS.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transfer Factor as an Option for Managing the COVID-19 Pandemic.

Folia biologica·2020
Same author

Transfer factor: an overlooked potential for the prevention and treatment of infectious diseases.

Folia biologica·2013
Same author

Immunotherapeutic approaches for renal cancer.

Folia biologica·2002
Same author

Lack of serologic association of human herpesvirus-8 (KSHV) in patients with monoclonal gammopathy of undetermined significance with and without progression to multiple myeloma.

Blood·2000
Same author

Preliminary observations using HIV-specific transfer factor in AIDS.

Biotherapy (Dordrecht, Netherlands)·1996
Same author

Preliminary results in HIV-1-infected patients treated with transfer factor (TF) and zidovudine (ZDV).

Biotherapy (Dordrecht, Netherlands)·1996

Area of Science:

  • Immunology
  • Molecular Biology
  • Virology

Background:

  • Biological science has achieved significant triumphs, yet challenges remain, particularly in understanding complex diseases like AIDS.
  • The concept of transfer factor, proposed over 40 years ago, challenges established immunological and molecular biology paradigms.
  • Despite its potential in treating viral infections, transfer factor is met with skepticism due to its unknown molecular structure and mode of action.

Purpose of the Study:

  • To challenge the prevailing scientific dogma surrounding transfer factor.
  • To advocate for the consideration of transfer factor in managing viral diseases, including AIDS.
  • To highlight the potential suppression of heterodox research that challenges established scientific paradigms.

Main Methods:

  • Review of existing scientific literature and historical context of transfer factor research.
  • Analysis of the challenges transfer factor faces within the current scientific paradigm.
  • Comparison of transfer factor's potential application against established treatments for viral infections.

Main Results:

  • The molecular structure and mode of action of transfer factor remain largely undefined, contradicting current scientific dogma.
  • Transfer factor has shown historical success in treating or preventing viral infections.
  • Heterodox research findings, like those on transfer factor, may be suppressed when they challenge dominant scientific paradigms.

Conclusions:

  • The scientific community should re-evaluate transfer factor, considering its potential despite existing prejudices.
  • The failure of current medical science to fully manage pandemics like AIDS necessitates an open-minded approach to alternative therapeutic concepts.
  • Scientific progress may require challenging and overthrowing established paradigms, akin to historical scientific revolutions.

Related Experiment Videos